VC Cell Therapy
A pharmaceutical company engaged in R&D, manufacturing, sale and distribution of regenerative medicines.
Launch date
Employees
Market cap
-
Enterprise valuation
€15—22m (Dealroom.co estimates Nov 2023.)
Kyotango Kyoto Prefecture (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Seed | |
* | $4.0m | Seed | |
| Total Funding | €3.6m | ||